The effect of a cyclooxygenase 2 inhibitor on early degenerated human nucleus pulposus explants

B.G.M. Dijk, van, E. Potier, R. Licht, L.B. Creemers, K. Ito

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

102 Downloads (Pure)


Study Design Preclinical in vitro culture of human degenerated nucleus pulposus (NP) tissue. Objective Cyclooxygenase 2 inhibitors (e.g., celecoxib) inhibit prostaglandin E2 (PGE2) production, and they have been shown to upregulate regeneration of articular cartilage. In this study, we developed an explant culture system for use with human tissue and tested the potential of celecoxib. Methods NP explants were cultured with or without 1 µM of celecoxib and were analyzed at days 0 and 7 for biochemical content (water, sulfated glycosaminoglycans, hydroxyproline, and DNA), gene expression (for disk matrix anabolic and catabolic markers), and PGE2 content. Results Water and biochemical contents as well as gene expression remained close to native values after 1¿week of culture. PGE2 levels were not increased in freshly harvested human NP tissue and thus were not reduced in treated tissues. Although no anabolic effects were observed at the dosage and culture duration used, no detrimental effects were observed and some specimens did respond by lowering PGE2. Conclusions Human degenerated NP explants were successfully cultured in a close to in vivo environment for 1 week. Further research, especially dosage-response studies, is needed to understand the role of PGE2 in low back pain and the potential of celecoxib to treat painful disks.
Originele taal-2Engels
Pagina's (van-tot)33-40
Aantal pagina's7
TijdschriftGlobal Spine Journal
Nummer van het tijdschrift1
StatusGepubliceerd - 2014


Duik in de onderzoeksthema's van 'The effect of a cyclooxygenase 2 inhibitor on early degenerated human nucleus pulposus explants'. Samen vormen ze een unieke vingerafdruk.

Citeer dit